LIVIVO - Search results -

Search results

Result 1 - 10 of total 83

Search options

Article ; Online: Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trial.

Ainsworth, Nicholas J / Brender, Ram / Gotlieb, Neta / Zhao, Haoyu / Blumberger, Daniel M / Karp, Jordan F / Lenze, Eric J / Nicol, Ginger E / Reynolds, Charles F / Wang, Wei / Mulsant, Benoit H

International psychogeriatrics

2023 Volume 35, Issue 12, Page(s) 707–716

Abstract: Objective: To investigate the relationship between lean muscle mass and treatment response in treatment-resistant late-life depression (TR-LLD). We hypothesized that lower lean muscle mass would be associated with older age, higher physical ... ...

Abstract	Objective: To investigate the relationship between lean muscle mass and treatment response in treatment-resistant late-life depression (TR-LLD). We hypothesized that lower lean muscle mass would be associated with older age, higher physical comorbidities, higher depressive symptom severity, and poorer treatment response. Design: Secondary analysis of a randomized, placebo-controlled trial. Setting: Three academic hospitals in the United States and Canada. Participants: Adults aged 60+ years with major depressive disorder who did not remit following open treatment with venlafaxine extended-release (XR) (n = 178). Measurements: We estimated lean muscle mass using dual-energy X-ray absorptiometry (DEXA) scans prior to and following randomized treatment with aripiprazole or placebo added to venlafaxine XR. Multivariate regressions estimated influence of demographic and clinical factors on baseline lean muscle mass, and whether baseline lean muscle mass was associated with treatment response, adjusted for treatment arm. Results: Low lean muscle mass was present in 22 (12.4%) participants. Older age and female sex, but not depressive symptom severity, were independently associated with lower lean muscle mass at baseline. Marital status, baseline depressive symptom severity, and treatment group were associated with improvement of depressive symptoms in the randomized treatment phase. Baseline lean muscle mass was not associated with improvement, regardless of treatment group. Conclusion: As expected, older age and female sex were associated with lower lean muscle mass in TR-LLD. However, contrary to prior results in LLD, lean muscle mass was not associated with depression severity or outcome. This suggests that aripiprazole augmentation may be useful for TR-LLD, even in the presence of anomalous body composition.clinicaltrials.gov Identifier: NCT00892047.
MeSH term(s)	Humans ; Female ; Venlafaxine Hydrochloride/therapeutic use ; Aripiprazole/therapeutic use ; Treatment Outcome ; Depression/therapy ; Depressive Disorder, Major/drug therapy ; Muscles ; Double-Blind Method
Chemical Substances	Venlafaxine Hydrochloride (7D7RX5A8MO) ; Aripiprazole (82VFR53I78)
Language	English
Publishing date	2023-01-03
Publishing country	England
Document type	Randomized Controlled Trial ; Journal Article
ZDB-ID	1038825-4
ISSN	1741-203X ; 1041-6102
ISSN (online)	1741-203X
ISSN	1041-6102
DOI	10.1017/S1041610222000862
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2621: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 513: Show issues

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Gender differences in how physicians access and process information.

Gotlieb, R / Abitbol, J / How, J A / Ben-Brith, I / Abenhaim, H A / Lau, S K / Basik, M / Rosberger, Z / Geva, N / Gotlieb, W H / Mintz, A

Gynecologic oncology reports

2019 Volume 27, Page(s) 50–53

Abstract: There is an absence of information on how physicians make surgical decisions, and on the effect of gender on the processing of information. A novel web based decision-matrix software was designed to trace experimentally the process of decision making in ... ...

Abstract	There is an absence of information on how physicians make surgical decisions, and on the effect of gender on the processing of information. A novel web based decision-matrix software was designed to trace experimentally the process of decision making in medical situations. The scenarios included a crisis and non-crisis simulation for endometrial cancer surgery. Gynecologic oncologists, fellows, and residents (42 male and 42 female) in Canada participated in this experiment. Overall, male physicians used more heuristics, whereas female physicians were more comprehensive in accessing clinical information (p < 0.03), utilized alternative-based acquisition processes in the non-crisis scenario (p = 0.01), were less likely to consider procedure-related costs (p = 0.04), and overall allocated more time to evaluate the information (p < 0.01). Further experiments leading to a better understanding of the cognitive processes involved in medical decision making could influence education and training and impact on patient outcome.
Language	English
Publishing date	2019-01-02
Publishing country	Netherlands
Document type	Journal Article ; Review
ZDB-ID	2818505-5
ISSN	2352-5789
ISSN	2352-5789
DOI	10.1016/j.gore.2018.12.008
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.

Galan, Alba / Papaluca, Arturo / Nejatie, Ali / Matanes, Emad / Brahimi, Fouad / Tong, Wenyong / Hachim, Ibrahim Yaseen / Yasmeen, Amber / Carmona, Euridice / Klein, Kathleen Oros / Billes, Sonja / Dawod, Ahmed E / Gawande, Prasad / Jeter, Anna Milik / Mes-Masson, Anne-Marie / Greenwood, Celia M T / Gotlieb, Walter H / Saragovi, H Uri

Frontiers in oncology

2023 Volume 13, Page(s) 1134763

Abstract: Background: Ovarian cancer (OC) is the deadliest gynecological cancer, often diagnosed at advanced stages. A fast and accurate diagnostic method for early-stage OC is needed. The tumor marker gangliosides, GD2 and GD3, exhibit properties that make them ... ...

Abstract	Background: Ovarian cancer (OC) is the deadliest gynecological cancer, often diagnosed at advanced stages. A fast and accurate diagnostic method for early-stage OC is needed. The tumor marker gangliosides, GD2 and GD3, exhibit properties that make them ideal potential diagnostic biomarkers, but they have never before been quantified in OC. We investigated the diagnostic utility of GD2 and GD3 for diagnosis of all subtypes and stages of OC. Methods: This retrospective study evaluated GD2 and GD3 expression in biobanked tissue and serum samples from patients with invasive epithelial OC, healthy donors, non-malignant gynecological conditions, and other cancers. GD2 and GD3 levels were evaluated in tissue samples by immunohistochemistry (n=299) and in two cohorts of serum samples by quantitative ELISA. A discovery cohort (n=379) showed feasibility of GD2 and GD3 quantitative ELISA for diagnosing OC, and a subsequent model cohort (n=200) was used to train and cross-validate a diagnostic model. Results: GD2 and GD3 were expressed in tissues of all OC subtypes and FIGO stages but not in surrounding healthy tissue or other controls. In serum, GD2 and GD3 were elevated in patients with OC. A diagnostic model that included serum levels of GD2+GD3+age was superior to the standard of care (CA125, p<0.001) in diagnosing OC and early-stage (I/II) OC. Conclusion: GD2 and GD3 expression was associated with high rates of selectivity and specificity for OC. A diagnostic model combining GD2 and GD3 quantification in serum had diagnostic power for all subtypes and all stages of OC, including early stage. Further research exploring the utility of GD2 and GD3 for diagnosis of OC is warranted.
Language	English
Publishing date	2023-04-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2649216-7
ISSN	2234-943X
ISSN	2234-943X
DOI	10.3389/fonc.2023.1134763
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Quantifying Alfalfa Yield Losses Caused by Foliar Diseases in Iowa, Ohio, Wisconsin, and Vermont.

Nutter, F W / Guan, J / Gotlieb, A R / Rhodes, L H / Grau, C R / Sulc, R M

Plant disease

2019 Volume 86, Issue 3, Page(s) 269–277

Abstract: Although foliar diseases of alfalfa occur throughout the United States wherever alfalfa is grown, little work has been done to quantify yield losses caused by foliar pathogens since the late 1980s. To quantify the yield losses caused by foliar diseases ... ...

Abstract	Although foliar diseases of alfalfa occur throughout the United States wherever alfalfa is grown, little work has been done to quantify yield losses caused by foliar pathogens since the late 1980s. To quantify the yield losses caused by foliar diseases of alfalfa, field experiments were performed in Iowa, Ohio, Vermont, and Wisconsin from 1995 to 1998. Different fungicides and fungicide application frequencies were used to obtain different levels of foliar disease in alfalfa. Visual disease and remote sensing assessments were performed weekly to determine the relationships between disease assessments and alfalfa yield. Visual disease assessments of percentage of defoliation, disease incidence, and disease severity were performed weekly, approximately five to six times during each alfalfa growth cycle. Remote sensing assessments also were obtained weekly by measuring the percentage of sunlight reflected from alfalfa canopies using handheld, multispectral radiometers. Yield loss estimates were calculated as the yield difference between the fungicide treatment with the highest yield and the nonfungicide control, divided by the yield obtained from the highest yielding fungicide treatment × 100. Over the 4-year period, significant alfalfa yield losses (P ≤ 0.05) occurred on 22 of the 48 harvest dates for the four states. The average significant yield loss for the 22 harvests was 19.3%. Both visual and percentage of reflectance assessments were used as independent variables in linear regression models to quantify the relationships between assessments and alfalfa yield. From 1995 to 1998, visual disease assessments were performed for a total of 209 dates and remote sensing assessments were performed on 198 dates from the four states. Yield models were developed for each of these assessment dates. There were 26/209, 26/209, and 17/209 significant yield models based on percentage of defoliation, disease incidence, and disease severity, respectively. Most of the significant models were for disease assessments performed on or within 1 or 2 weeks of the date of alfalfa harvest. When the significant models were averaged, percentage of defoliation, disease incidence, and disease severity explained 51, 55, and 52% of the variation in alfalfa yield, respectively. There were a total of 68/198 significant alfalfa yield models based on remote sensing assessments, and the significant models (averaged) explained 62% of the variation in alfalfa yield. Alfalfa foliar diseases continue to have a significant negative impact on alfalfa yields in the United States and remote sensing appears to offer a better means to quantify the impact of foliar diseases on alfalfa yield compared with visual assessment methods.
Language	English
Publishing date	2019-02-28
Publishing country	United States
Document type	Journal Article
ZDB-ID	754182-x
ISSN	0191-2917
ISSN	0191-2917
DOI	10.1094/PDIS.2002.86.3.269
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Bonn / Germany

Z 2043: Show issues

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.

Marchocki, Zibi / Cusimano, Maria C / Clarfield, Lauren / Kim, Soyoun Rachel / Fazelzad, Rouhi / Espin-Garcia, Osvaldo / Bouchard-Fortier, Geneviève / Rossi, Emma C / Stewart, Katherine I / Soliman, Pamela T / How, Jeffrey A / Gotlieb, Walter H / Holloway, Robert W / Ianieri, Manuel M / Cabrera, Silvia / Lim, Yong Kuei / Ferguson, Sarah E

American journal of obstetrics and gynecology

2021 Volume 225, Issue 4, Page(s) 367.e1–367.e39

Abstract: Objective: A sentinel lymph node biopsy is widely accepted as the standard of care for surgical staging in low-grade endometrial cancer, but its value in high-grade endometrial cancer remains controversial. The aim of this systematic review and meta- ... ...

Abstract	Objective: A sentinel lymph node biopsy is widely accepted as the standard of care for surgical staging in low-grade endometrial cancer, but its value in high-grade endometrial cancer remains controversial. The aim of this systematic review and meta-analysis was to evaluate the performance characteristics of sentinel lymph node biopsy in patients with endometrial cancer with high-grade histology (registered in the International Prospective Register of Systematic Reviews with identifying number CRD42020160280). Data sources: We systematically searched the MEDLINE, Epub Ahead of Print, MEDLINE In-Process & Other Non-Indexed Citations, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Embase databases all through the OvidSP platform. The search was performed between January 1, 2000, and January 26, 2021. ClinicalTrials.gov was searched to identify ongoing registered clinical trials. Study eligibility criteria: We included prospective cohort studies in which sentinel lymph node biopsy were evaluated in clinical stage I patients with high-grade endometrial cancer (grade 3 endometrioid, serous, clear cell, carcinosarcoma, mixed, undifferentiated or dedifferentiated, and high-grade not otherwise specified) with a cervical injection of indocyanine green for sentinel lymph node detection and at least a bilateral pelvic lymphadenectomy as a reference standard. If the data were not reported specifically for patients with high-grade histology, the authors were contacted for aggregate data. Methods: We pooled the detection rates and measures of diagnostic accuracy using a generalized linear mixed-effects model with a logit and assessed the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Results: We identified 16 eligible studies of which the authors for 9 of the studies provided data on 429 patients with high-grade endometrial cancer specifically. The study-level median age was 66 years (range, 44-82.5 years) and the study-level median body mass index was 28.6 kg/m Conclusion: Sentinel lymph node biopsy accurately detect lymph node metastases in patients with high-grade endometrial cancer with a false negative rate comparable with that observed in low-grade endometrial cancer, melanoma, vulvar cancer, and breast cancer. These findings suggest that sentinel lymph node biopsy can replace complete lymphadenectomies as the standard of care for surgical staging in patients with high-grade endometrial cancer.
MeSH term(s)	Adenocarcinoma, Clear Cell/pathology ; Adenocarcinoma, Clear Cell/surgery ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/surgery ; Carcinosarcoma/pathology ; Carcinosarcoma/surgery ; Coloring Agents ; Endometrial Neoplasms/pathology ; Endometrial Neoplasms/surgery ; Female ; Humans ; Indocyanine Green ; Lymph Node Excision ; Neoplasm Grading ; Neoplasms, Cystic, Mucinous, and Serous/pathology ; Neoplasms, Cystic, Mucinous, and Serous/surgery ; Sentinel Lymph Node/pathology ; Sentinel Lymph Node Biopsy
Chemical Substances	Coloring Agents ; Indocyanine Green (IX6J1063HV)
Language	English
Publishing date	2021-05-29
Publishing country	United States
Document type	Journal Article ; Meta-Analysis ; Systematic Review
ZDB-ID	80016-8
ISSN	1097-6868 ; 0002-9378
ISSN (online)	1097-6868
ISSN	0002-9378
DOI	10.1016/j.ajog.2021.05.034
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Um I Zs.152: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

How, J / Gotlieb, W H / Press, J Z / Abitbol, J / Pelmus, M / Ferenczy, A / Probst, S / Gotlieb, R / Brin, S / Lau, S

Gynecologic oncology

2015 Volume 137, Issue 3, Page(s) 436–442

Abstract: Background and aims: With the debate over extent of lymphadenectomy in endometrial cancer, sentinel lymph node (SLN) mapping may provide a focused approach to evaluate the most relevant lymph nodes (LN) while minimizing the complications. We evaluated ... ...

Abstract	Background and aims: With the debate over extent of lymphadenectomy in endometrial cancer, sentinel lymph node (SLN) mapping may provide a focused approach to evaluate the most relevant lymph nodes (LN) while minimizing the complications. We evaluated SLN mapping using filtered technetium(99), indocyanine green (ICG), and blue dye. Methods: Prospective evaluation of 100 patients who underwent SLN mapping by using submucosal and deep stromal cervical injections of technetium(99), ICG, and blue dye as part of the staging for endometrial cancer. Results: 286 SLNs were mapped (2.9 per patient) in 92% of patients. The bilateral detection rate was 76%. ICG had a significantly higher SLN detection rate than blue dye in both overall (87% vs 71%, respectively; p=0.005) and bilateral (65% vs 43%, respectively; p=0.002) detection, but similar SLN detection rates compared to technetium(99) in both overall (87% vs 88%, respectively; p=0.83) and bilateral (65% vs 71%, respectively; p=0.36) detection. In eight cases, the SLN was in the para-aortic area and in 14 cases in the pre-sacral, hypogastric vein, or parametrial area. In nine cases, the SLN was positive for metastasis, and in seven cases the SLN was the only positive node. One SLN was falsely negative. No complications or anaphylactic reactions occurred. Conclusion: Intra-operative SLN mapping using cervical injection is feasible in patients with endometrial cancer and yields adequate detection rates. It allows mapping of SLNs in areas (pre-sacral, hypogastric vein, parametrial) not routinely sampled. Given the poorer performance of blue dye, surgeons may omit its use if a combination of ICG and technetium(99) is used.
MeSH term(s)	Coloring Agents/administration & dosage ; Endometrial Neoplasms/pathology ; Endometrial Neoplasms/rehabilitation ; Female ; Humans ; Indocyanine Green/administration & dosage ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Middle Aged ; Radionuclide Imaging ; Radiopharmaceuticals/administration & dosage ; Sentinel Lymph Node Biopsy/methods ; Technetium Tc 99m Sulfur Colloid/administration & dosage
Chemical Substances	Coloring Agents ; Radiopharmaceuticals ; Technetium Tc 99m Sulfur Colloid (556Q0P6PB1) ; Indocyanine Green (IX6J1063HV)
Language	English
Publishing date	2015-06
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	801461-9
ISSN	1095-6859 ; 0090-8258
ISSN (online)	1095-6859
ISSN	0090-8258
DOI	10.1016/j.ygyno.2015.04.004
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 885: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Immunologie de la grossesse.

Gotlieb, W H

Revue medicale de Bruxelles

1992 Volume 13, Issue 4, Page(s) 97–101

Abstract: The fetus expresses paternally inherited gene products and tissue-specific differentiation antigens. Hence, it can be considered as a semi-allogeneic graft towards which the maternal immune response is characterized by tolerance instead of rejection. As ... ...

Title translation	Immunology of pregnancy.
Abstract	The fetus expresses paternally inherited gene products and tissue-specific differentiation antigens. Hence, it can be considered as a semi-allogeneic graft towards which the maternal immune response is characterized by tolerance instead of rejection. As such, the pregnancy represents a challenge to the laws of transplantation. For the immunologist, the question is not why some women miscarry, but rather, why most women do not miscarry? A bulwark of proscriptive or inhibitory influences must be built to ensure an absence of anti-fetal reactivity. The mechanisms underlying the induction of tolerance are poorly understood. Failure to obtain an adequate maternal immune response might be responsible for some forms of miscarriages, especially recurrent spontaneous abortions. Increased knowledge of those mechanisms could have implications in various fields, such as infertility, transplantation and oncology.
MeSH term(s)	Abortion, Spontaneous/immunology ; Antibody Formation ; Antigens, Differentiation/immunology ; Cytokines/immunology ; Female ; Fetus/immunology ; Humans ; Immune Tolerance ; Isoantibodies/biosynthesis ; Pregnancy/immunology
Chemical Substances	Antigens, Differentiation ; Cytokines ; Isoantibodies
Language	French
Publishing date	1992-04
Publishing country	Belgium
Document type	English Abstract ; Journal Article ; Review
ZDB-ID	760217-0
ISSN	0035-3639
ISSN	0035-3639
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 2387: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?

Vetter, M H / Smrz, S / Gehrig, P A / Peng, K / Matsuo, K / Davidson, B A / Cisa, M P / Lees, B F / Brunette, L L / Tucker, K / Stuart Staley, A / Gotlieb, W H / Holloway, R W / Essel, K G / Holman, L L / Goldfeld, E / Olawaiye, A / Rose, S / Uppal, S /

Bixel, K

Gynecologic oncology

2020 Volume 159, Issue 2, Page(s) 354–358

Abstract: Objective: The objective of this study was to assess the rate of discordance between clinical and pathologic tumor size for women with stage IB1 cervical cancer (FIGO 2009 criteria), assess risk factors for discordance, and determine the impact of ... ...

Abstract	Objective: The objective of this study was to assess the rate of discordance between clinical and pathologic tumor size for women with stage IB1 cervical cancer (FIGO 2009 criteria), assess risk factors for discordance, and determine the impact of discordance on oncologic outcomes. Methods: This was a secondary analysis of a prior multi-institutional retrospective review of patients diagnosed with stage IB1 (FIGO 2009 staging) cervical cancer undergoing radical hysterectomy between 2010 and 2017. Demographic, clinicopathologic, and oncologic data were collected. Pathologic upstaging was defined as having a preoperative diagnosis of stage IB1 cervical cancer with pathology demonstrating a tumor size >4 cm. Demographic and clinicopathologic data was compared using chi-square, fisher exact or 2-sided t-test. Survival was estimated using the Kaplan-Meier method. Results: Of the 630 patients, 77 (12%) were upstaged. Patients who were upstaged had lower rates of preoperative conization (p < .001) or preoperative tumor sizes ≤2 cm (p < .001). Upstaged patients had increased odds of deep stromal invasion, lymphovascular space invasion, positive margins and positive lymph nodes. Almost 88% of upstaged patients received adjuvant therapy compared to 29% of patients with tumors ≤4 cm (odds 18.49, 95% CI 8.99-37.94). Finally, pathologic upstaging was associated with an increased hazard of recurrence (hazard ratio [HR] 1.95, 95% CI 1.03-3.67) and all-cause death (HR 2.31, 95% CI 1.04-5.11). Conclusions: Pathologic upstaging in stage IB1 cervical cancer is relatively common. Upstaging is associated with an 18-fold increased risk of receipt of adjuvant therapy. Patients undergoing preoperative conization and those with tumors <2 cm had lower risks of upstaging. Improvement in preoperative assessment of tumor size may better inform primary treatment decisions.
MeSH term(s)	Aged ; Chemotherapy, Adjuvant/statistics & numerical data ; Conization/statistics & numerical data ; Female ; Humans ; Hysterectomy/statistics & numerical data ; Lymph Node Excision/statistics & numerical data ; Middle Aged ; Neoplasm Invasiveness/pathology ; Neoplasm Staging/methods ; Retrospective Studies ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/surgery
Language	English
Publishing date	2020-09-02
Publishing country	United States
Document type	Journal Article ; Multicenter Study
ZDB-ID	801461-9
ISSN	1095-6859 ; 0090-8258
ISSN (online)	1095-6859
ISSN	0090-8258
DOI	10.1016/j.ygyno.2020.08.004
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 885: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Holloway, Robert W / Abu-Rustum, Nadeem R / Backes, Floor J / Boggess, John F / Gotlieb, Walter H / Jeffrey Lowery, W / Rossi, Emma C / Tanner, Edward J / Wolsky, Rebecca J

Gynecologic oncology

2017 Volume 146, Issue 2, Page(s) 405–415

Abstract: The emphasis in contemporary medical oncology has been "precision" or "personalized" medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar attempts at precision are occurring in surgical oncology. Sentinel lymph ... ...

Abstract	The emphasis in contemporary medical oncology has been "precision" or "personalized" medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar attempts at precision are occurring in surgical oncology. Sentinel lymph node (SLN) mapping has recently been introduced into the surgical staging of endometrial cancer with the goal to reduce morbidity associated with comprehensive lymphadenectomy, yet obtain prognostic information from lymph node status. The Society of Gynecologic Oncology's (SGO) Clinical Practice Committee and SLN Working Group reviewed the current literature for preparation of this document. Literature-based recommendations for the inclusion of SLN assessment in the treatment of patients with endometrial cancer are presented. This article examines.
MeSH term(s)	Adenocarcinoma, Clear Cell/pathology ; Adenocarcinoma, Clear Cell/surgery ; Carcinoma, Endometrioid/pathology ; Carcinoma, Endometrioid/surgery ; Carcinosarcoma/pathology ; Carcinosarcoma/surgery ; Colorimetry ; Coloring Agents ; Endometrial Neoplasms/pathology ; Endometrial Neoplasms/surgery ; Female ; Gynecology ; Humans ; Indocyanine Green ; Lymph Node Excision ; Neoplasm Staging ; Neoplasms, Cystic, Mucinous, and Serous/pathology ; Neoplasms, Cystic, Mucinous, and Serous/surgery ; Organotechnetium Compounds ; Sentinel Lymph Node/pathology ; Sentinel Lymph Node Biopsy/methods ; Single Photon Emission Computed Tomography Computed Tomography ; Societies, Medical ; Spectroscopy, Near-Infrared ; Surgical Oncology
Chemical Substances	Coloring Agents ; Organotechnetium Compounds ; Indocyanine Green (IX6J1063HV)
Language	English
Publishing date	2017-05-28
Publishing country	United States
Document type	Consensus Development Conference ; Journal Article ; Review
ZDB-ID	801461-9
ISSN	1095-6859 ; 0090-8258
ISSN (online)	1095-6859
ISSN	0090-8258
DOI	10.1016/j.ygyno.2017.05.027
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 885: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca

Xue, Yibo / Morris, Jordan L / Yang, Kangning / Fu, Zheng / Zhu, Xianbing / Johnson, Fraser / Meehan, Brian / Witkowski, Leora / Yasmeen, Amber / Golenar, Tunde / Coatham, Mackenzie / Morin, Geneviève / Monast, Anie / Pilon, Virginie / Fiset, Pierre Olivier / Jung, Sungmi / Gonzalez, Anne V / Camilleri-Broet, Sophie / Fu, Lili /

Postovit, Lynne-Marie / Spicer, Jonathan / Gotlieb, Walter H / Guiot, Marie-Christine / Rak, Janusz / Park, Morag / Lockwood, William / Foulkes, William D / Prudent, Julien / Huang, Sidong

Nature communications

2023 Volume 14, Issue 1, Page(s) 1552

Language	English
Publishing date	2023-03-21
Publishing country	England
Document type	Published Erratum
ZDB-ID	2553671-0
ISSN	2041-1723 ; 2041-1723
ISSN (online)	2041-1723
ISSN	2041-1723
DOI	10.1038/s41467-023-37144-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Bonn / Germany

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito